Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer – Drug Discovery & Development


Drug Discovery & Development

Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer
Drug Discovery & Development
Cancer Research UK and Cancer Research Technology–the charity's development and commercialization arm–have reached an agreement with AstraZeneca to take AZD2098, an experimental drug originally designed for asthma, into a clinical trial to treat 
Cancer Research UK to Repurpose AstraZeneca Asthma Drug for Kidney CancerGenetic Engineering News

all 2 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.